Amplifon SpA

Italy Country flag Italy
Sector: Medical Supplies
Ticker: AMP
ISIN: IT0004056880
Factsheet Factsheet

Market multiple valuation of Amplifon SpA ( AMP | ITA)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of Amplifon SpA is significantly higher than the median of its peer group: around 12.00. The company valuation of Amplifon SpA according to these metrics is way above the market valuation of its peer group.
The P/Earnings NTM ratio of Amplifon SpA is slightly higher than the average of its sector (Medical Supplies): 14.92. The company valuation of Amplifon SpA according to these metrics is consistent with the market valuation of its sector.
The P/Earnings NTM ratio of Amplifon SpA is significantly lower than its historical 5-year average: 34.6. The (current) company valuation of Amplifon SpA is therefore way below its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2025P/E NTM
Amplifon SpAFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies10.2012.5414.92
Cboe IT 4015.1212.5912.23
Italy9.6710.6210.31
More...
Beta (Ref: Cboe IT 40)
Levered betaUnlevered beta
1-Year0.530.46
2-Year0.650.56
3-Year0.660.57
More...
Stock Perf excl. Dividends (in EUR)
AMPCboe IT 40Rel. Perf.
Year-to-Date-30.1%12.4%-42.6%
1-Week2.0%2.7%-0.7%
1-Month-6.1%-0.3%-5.8%
1-Year-45.1%15.4%-60.5%
3-Year-53.8%66.3%-120.2%
5-Year-17.0%115.7%-132.7%
More...
International Peers - Amplifon SpA
Company NameCtryMarket
Cap.
last (mUSD)
Amplifon SpAITA-0.00
International Peers Median0.32
DENTSPLY SIRONA Inc.USA2 854
Coloplast A/SDNK22 101
Hologic Inc.USA12 712
Zimmer Biomet Holdings ...USA20 381
EBOS Group LimitedNZL4 228
GPRV Analysis
Created with Highcharts 4.1.70/102/104/106/108/1010/10
Amplifon SpA
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
Created with Highcharts 4.1.7Millions EUR201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k1k2k3k4k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Amplifon SpA
  • Cboe IT 40
Created with Highcharts 4.1.7Jan '25Sep '24May '25-75%-50%-25%0%25%
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).